- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones
Patent holdings for IPC class C07K 16/26
Total number of patents in this class: 1005
10-year publication summary
|
82
|
69
|
94
|
70
|
72
|
64
|
62
|
67
|
61
|
53
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| H. Lundbeck A/S | 1232 |
44 |
| Adrenomed AG | 42 |
24 |
| Amgen Inc. | 4436 |
20 |
| Eli Lilly and Company | 4114 |
20 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3289 |
20 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
18 |
| Progastrine et Cancers S.A R.L. | 24 |
17 |
| Centre National de La Recherche Scientifique | 11077 |
16 |
| Teva Pharmaceuticals International GmbH | 326 |
15 |
| F. Hoffmann-La Roche AG | 7800 |
13 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3327 |
13 |
| Intrinsic Lifesciences LLC | 16 |
10 |
| Les Laboratoires Servier | 497 |
10 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
10 |
| Board of Regents, The University of Texas System | 6149 |
9 |
| B.r.a.h.m.s GmbH | 195 |
9 |
| Universitat Ulm | 117 |
9 |
| H. Lundbeck A/S | 17 |
9 |
| Vaccinvent GmbH | 15 |
9 |
| Roche Diagnostics Operations, Inc. | 1523 |
8 |
| Other owners | 702 |